These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1099548)

  • 1. [Methodological aspects of clinical evaluation of coronary agents].
    Jasiński K; Wierzchowiecki M; Poprawski K
    Pol Arch Med Wewn; 1975 Aug; 54(2):215-21. PubMed ID: 1099548
    [No Abstract]   [Full Text] [Related]  

  • 2. [Carbochromen in therapy of acute and chronic coronary insufficiency].
    Votcal BE; Lozinskij LG
    Arzneimittelforschung; 1970 Mar; 20():459-60. PubMed ID: 4989254
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of lidoflazine as an anti-anginal drug.
    Vohra JK; Sloman JG
    Cardiology; 1973; 58(4):209-19. PubMed ID: 4206284
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term evaluation of lidoflazine in angina pectoris based on exercise tolerance.
    Piessens J; De Geest H
    Cardiology; 1972; 57(3):135-49. PubMed ID: 4557527
    [No Abstract]   [Full Text] [Related]  

  • 5. [Controlled evaluation of treatment with an antianginous drug of patients with coronary disease].
    Alberto S; Lavarino A
    Minerva Cardioangiol; 1973 Oct; 21(10):672-6. PubMed ID: 4589191
    [No Abstract]   [Full Text] [Related]  

  • 6. [Angina pectoris by effort. Effect of Bay a 1040].
    Arce Gómez E; Aspe y Rosas J; Alcocer Diaz L
    Prensa Med Mex; 1976; 41(1-2):56-62. PubMed ID: 778824
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trials of anti-angina drugs].
    Camerini E; Alberti E; Borgioni L; Medugno G; Scardi S
    G Ital Cardiol; 1976; 6(7):1291-304. PubMed ID: 13024
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with the use of Intensain in the coronary syndrome].
    Ivanchich R; Pershich T; Chustovich F
    Kardiologiia; 1969 Jul; 9(7):69-73. PubMed ID: 4906448
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the antianginal effects of foridon by transesophageal stimulation of the left atrium].
    Vishnevskiĭ VI; Gromnatskiĭ NI
    Sov Med; 1990; (6):75-7. PubMed ID: 2396130
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences with the use of carbochromen in coronary syndrome].
    Ivancić R; Persić T; Custović F
    Arzneimittelforschung; 1970 Mar; 20():454-6. PubMed ID: 4916580
    [No Abstract]   [Full Text] [Related]  

  • 11. [Perhexiline maleate in angina pectoris. Study of tolerance to treadmill exercise].
    Souza AD
    Arq Bras Cardiol; 1973 Aug; 26 Suppl 1():83-8. PubMed ID: 4595480
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Effects of perhexiline maleate in angina pectoris: a double-blind clinical evaluation with ECG-treadmill exercise testing.
    Morledge J
    Postgrad Med J; 1973 Apr; 49():Suppl 3:64-7. PubMed ID: 4587034
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of "intensain" to improve exercise tolerance in patients with angina pectoris.
    Conway N; Gupta GD; Sowton E
    Acta Cardiol; 1968; 23(5):434-8. PubMed ID: 4886340
    [No Abstract]   [Full Text] [Related]  

  • 14. [The efficacy of 2 new drug forms of isosorbide-5-mononitrate in patients with stable stenocardia of effort].
    Metelitsa VI; Martsevich SIu; Kutishenko NP; Kozyreva MP; Blagodatskikh SV; Simkhaev LS; Slastnikova ID; Vakulovskaia MK
    Ter Arkh; 1994; 66(8):22-5. PubMed ID: 7985147
    [No Abstract]   [Full Text] [Related]  

  • 15. [New drug (Sensit) for the treatment of coronary disease in a double blind test].
    Pillen D
    Fortschr Med; 1974 Jun; 92(16):709-11. PubMed ID: 4600940
    [No Abstract]   [Full Text] [Related]  

  • 16. Treadmill exercise-tolerance test behavior in anginal patients treated with perhexiline maleate.
    Alcocer L; Aspe J; Arce-Gomez E
    Curr Ther Res Clin Exp; 1974 Mar; 16(3):163-70. PubMed ID: 4206724
    [No Abstract]   [Full Text] [Related]  

  • 17. [Importance of the placebo in the clinical evaluation of so-called coronary vasodilator agents in patients with clinical manifestations of angina pectoris].
    Calandre L; Ruano JM
    Rev Esp Cardiol; 1965 Apr; 18(2):168-72. PubMed ID: 5319557
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical study of a new anti-angina pectoris agent: Fenalcomine hydrochloride].
    ?Warembourg H; Thery C
    Lille Med; 1975 Jan; 20(1):79-82. PubMed ID: 1134178
    [No Abstract]   [Full Text] [Related]  

  • 19. [Double-blind clinical trial of a new coronary-active drug, MD 6753].
    Dalla Volta S
    Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical effect of 4-(2'-nitrophenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine (BAY a 1040) on angina pectoris evaluated by sequential analysis.
    Kimura E; Mabuchi G; Kikuchi H
    Arzneimittelforschung; 1972 Feb; 22(2):365-7. PubMed ID: 4623700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.